ISC8, Inc. (ISCI) Signs Agreement with a Leading UK Mobile Operator
ISC8, a provider of intelligent cyber security solutions, announced today the entrance into a one-year support agreement with a prominent…
Blog
5BARz International Inc. (BARZ) Patented Technology for Cell Phone Signal Boosters Meet and Exceed Requirements Set by the FCC
On February 20, 2013, the FCC issued a Report & Order on Signal Boosters which includes rules, policies and specific…
Premier Biomedical, Inc. (BIEL) Posts Favorable Phase 1 Clinical Trial for Breast Cancer Treatment
Premier Biomedical has released the results of a completed phase 1 mouse testing of its breast cancer therapy, with results…
Frozen Food Gift Group, Inc. (FROZ) Serves Diverse and Growing Client Base
Frozen Food Gift Group, through the company’s wholly owned subsidiary, Miami Ice Machine Company (MIMCO), is a leading provider of…
BIO-key International, Inc. (BKYI) TruDonor Fingerprint Identification System Implemented by Suncoast Communities Blood Bank
BIO-key International has announced that Suncoast Communities Blood Bank (SCBB) has successfully launched the company’s TruDonor donor search and identification…
Cardium Therapeutics, Inc. (CXM) Positioned to Advance Leading Products with Experienced Leadership at the Helm
Cardium Therapeutics has established a diversified portfolio of medical products with large market potential. Armed with a capital-efficient, asset-based business…
5BARz International, Inc. (BARZ) Appoints Behrooz Lessani as the Company’s Vice President of Business Development
5BARz International, in establishing it's position as a leader in providing wireless coverage solutions using network extender devices, has today…
5BARz International, Inc. (BARZ) Appoints Behrooz Lessani as the Company's Vice President of Business Development
5BARz International, in establishing it's position as a leader in providing wireless coverage solutions using network extender devices, has today…
DoMark International, Inc. (DOMK) Successfully Targets Critical Mobile Charging Market
DoMark International seeks out companies offering profitable technologies with proven markets. It’s a term that perfectly describes the company’s primary…
Anthera Pharmaceuticals, Inc. (ANTH) Initiates BRIGHT-SC Phase 2 Clinical Study of Blisibimod for Treating IgA Nephropathy
Biopharmaceutical company Anthera Pharmaceuticals has announced the initiation of the BRIGHT-SC Phase 2 study of blisibimod, which is a novel…